Case Study: Excision BioTherapeutics achieves cost efficiencies with Vena Solutions

Excision BioTherapeutics Unlocks Cost Efficiencies With Vena

Excision BioTherapeutics, a biotech company developing CRISPR-based therapies, needed a more flexible way to budget, forecast, and report finances as a small team managing tight cash burn. The company chose Vena Solutions and its Excel-native budgeting and financial reporting platform, along with integrations to Sage Intacct, to improve visibility and identify cost efficiencies.

Vena Solutions implemented automated data aggregation, workflow notifications, secure templates, and drill-down capabilities in about six weeks. As a result, Excision BioTherapeutics cut monthly data aggregation from 3–4 weeks to 1 week, reduced variance analysis from 10 hours to 4 hours, and gained real-time reporting that helped avoid the need for an additional FP&A hire and keep overall costs down.

Excision BioTherapeutics

Sal Amato

Senior Director, Finance